Request for Covid-19 Impact Assessment of this Report

Diagnostic and Biotech

Global Spine Biologics Industry 2016 Deep Market Research Report

  • QYR631071
  • 172 Pages
  • July 2016
  • Diagnostic and Biotech
Download Sample    Get Discount   
 
The Global Spine Biologics Industry 2016 Market Research Report is a professional and in-depth study on the current state of the spine biologics industry.

The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The spine biologics market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status.

Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.

The report focuses on global major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The spine biologics industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.

With 276 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

Table of Contents

1 Industry Overview 1

1.1 Definition and Specifications of Spine Biologics 1

1.1.1 Definition of Spine Biologics 1

1.1.2 Specifications of Spine Biologics 2

1.2 Classification of Spine Biologics 3

1.2.1 Bone Graft 4

1.2.2 Bone Graft Substitute 4

1.2.3 Platelet Rich Plasma 5

1.2.4 BMAC 5

1.3 Applications of Spine Biologics 6

1.3.1 Anterior Cervical Discectomy and Fusion 7

1.3.2 Posterior Lumbar Interbody Fusion 7

1.4 Industry Chain Structure of Spine Biologics 8

1.5 Industry Overview and Major Regions Status of Spine Biologics 8

1.5.1 Industry Overview of Spine Biologics 8

1.5.2 Global Major Regions Status of Spine Biologics 9

1.6 Industry Policy Analysis of Spine Biologics 10

1.7 Industry News Analysis of Spine Biologics 12

2 Manufacturing Cost Structure Analysis of Spine Biologics 15

2.1 Raw Material Suppliers Analysis of Spine Biologics 15

2.2 Equipment Suppliers Analysis of Spine Biologics 16

2.3 Labor Cost Analysis of Spine Biologics 16

2.4 Other Costs Analysis of Spine Biologics 19

2.5 Manufacturing Cost Structure Analysis of Spine Biologics 20

2.6 Manufacturing Process Analysis of Spine Biologics 21

3 Technical Data and Manufacturing Plants Analysis 22

3.1 Capacity of Global Key Manufacturers in 2015 22

3.2 Key Manufacturing Plants Distribution of Global Key Spine Biologics Manufacturers in 2015 22

3.3 R&D Status and Technology Source of Global Spine Biologics Key Manufacturers in 2015 23

4 Capacity, Production and Revenue Analysis of Spine Biologics by Regions, Types and Manufacturers 24

4.1 Global Capacity, Production and Revenue of Spine Biologics by Regions 2011-2016 24

4.2 Global and Major Regions Capacity, Production, Revenue and Growth Rate of Spine Biologics 2011-2016 27

4.3 Global Production and Revenue of Spine Biologics by Types 2011-2016 33

4.4 Global Capacity, Production and Revenue of Spine Biologics by Manufacturers 2011-2016 36

5 Price, Cost, Gross and Gross Margin Analysis of Spine Biologics by Regions, Types and Manufacturers 43

5.1 Price, Cost, Gross and Gross Margin Analysis of Spine Biologics by Regions 2011-2016 43

5.2 Price, Cost, Gross and Gross Margin Analysis of Spine Biologics by Types 2011-2016 46

5.3 Price, Cost, Gross and Gross Margin Analysis of Spine Biologics by Manufacturers 2011-2016 49

6 Consumption Volume, Consumption Value and Sale Price Analysis of Spine Biologics by Regions, Types and Applications 54

6.1 Global Consumption Volume and Consumption Value of Spine Biologics by Regions 2011-2016 54

6.2 Global and Major Regions Consumption Volume, Consumption Value and Growth Rate of Spine Biologics 2011-2016 57

6.3 Global Consumption Volume and Consumption Value of Spine Biologics by Types 2011-2016 62

6.4 Global Consumption Volume and Consumption Value of Spine Biologics by Applications 2011-2016 65

6.5 Sale Price of Spine Biologics by Regions 2011-2016 68

6.6 Sale Price of Spine Biologics by Types 2011-2016 68

6.7 Sale Price of Spine Biologics by Applications 2011-2016 69

7 Supply, Import, Export and Consumption Analysis of Spine Biologics 70

7.1 Supply, Consumption and Gap of Spine Biologics 2011-2016 70

7.2 Global Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Spine Biologics 2011-2016 71

7.3 North America Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Spine Biologics 2011-2016 72

7.4 Europe Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Spine Biologics 2011-2016 73

7.5 Asia Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Spine Biologics 2011-2016 74

8 Analysis of Spine Biologics Industry Key Manufacturers 75

8.1 Medtronic 75

8.1.1 Company Profile 75

8.1.2 Product Information 76

8.1.3 Capacity, Production, Price, Cost, Gross, and Revenue 76

8.2 Depuy Synthes 78

8.2.1 Company Profile 78

8.2.2 Product Information 79

8.2.3 Capacity, Production, Price, Cost, Gross, and Revenue 80

8.3 Stryker Corporation 81

8.3.1 Company Profile 81

8.3.2 Product Information 82

8.3.3 Capacity, Production, Price, Cost, Gross, and Revenue 83

8.4 Nuvasive 84

8.4.1 Company Profile 84

8.4.2 Product Information 85

8.4.3 Capacity, Production, Price, Cost, Gross, Revenue and Gross Margin 86

8.5 Zimmer Biomet 87

8.5.1 Company Profile 87

8.5.2 Product Information 88

8.5.3 Capacity, Production, Price, Cost, Gross, and Revenue 89

8.6 Orthofix International 90

8.6.1 Company Profile 90

8.6.2 Product Information 91

8.6.3 Capacity, Production, Price, Cost, Gross, Revenue and Gross Margin 91

8.7 Globus Medical 93

8.7.1 Company Profile 93

8.7.2 Product Information 94

8.7.3 Capacity, Production, Price, Cost, Gross, Revenue and Gross Margin 94

8.8 Alphatec spine 96

8.8.1 Company Profile 96

8.8.2 Product Information 97

8.8.3 Capacity, Production, Price, Cost, Gross, Revenue and Gross Margin 97

8.9 K2M 99

8.9.1 Company Profile 99

8.9.2 Product Information 100

8.9.3 Capacity, Production, Price, Cost, Gross, and Revenue 100

8.10 Exactech 102

8.10.1 Company Profile 102

8.10.2 Product Information 103

8.10.3 Capacity, Production, Price, Cost, Gross, and Revenue 103

8.11 Wright Medical Technology 105

8.11.1 Company Profile 105

8.11.2 Product Information 106

8.11.3 Capacity, Production, Price, Cost, Gross, Revenue and Gross Margin 106

8.12 X-Spine Systems 108

8.12.1 Company Profile 108

8.12.2 Product Information 109

8.12.3 Capacity, Production, Price, Cost, Gross, Revenue and Gross Margin 109

8.13 Nutech 111

8.13.1 Company Profile 111

8.13.2 Product Information 112

8.13.3 Capacity, Production, Price, Cost, Gross, and Revenue 112

8.14 Arthrex 114

8.14.1 Company Profile 114

8.14.2 Product Information 115

8.14.3 Capacity, Production, Price, Cost, Gross, and Revenue 115

9 Marketing Trader or Distributor Analysis of Spine Biologics 117

9.1 Marketing Channels Status of Spine Biologics 117

9.2 Traders or Distributors with Contact Information of Spine Biologics 118

9.3 Ex-work Price, Channel Price and End Buyer Price Analysis of Spine Biologics 119

9.4 Regional Import, Export and Trade Analysis of Spine Biologics 119

11 Development Trend of Analysis of Spine Biologics 121

11.1 Capacity, Production and Revenue Forecast of Spine Biologics by Regions and Types 121

11.1.1 Global Capacity, Production and Revenue of Spine Biologics by Regions 2016-2021 121

11.1.2 Global and Major Regions Capacity, Production, Revenue and Growth Rate of Spine Biologics 2016-2021 124

11.1.3 Global Capacity, Production and Revenue of Spine Biologics by Types 2016-2021 129

11.2 Consumption Volume and Consumption Value Forecast of Spine Biologics by Regions, Types and Applications 132

11.2.1 Global Consumption Volume and Consumption Value of Spine Biologics by Regions 2016-2021 132

11.2.2 Global and Major Regions Consumption Volume, Consumption Value and Growth Rate of Spine Biologics 2016-2021 135

11.2.3 Global Consumption Volume and Consumption Value of Spine Biologics by Types 2016-2021 140

11.2.4 Global Consumption Volume and Consumption Value of Spine Biologics by Applications 2016-2021 143

11.3 Supply, Import, Export and Consumption Forecast of Spine Biologics 146

11.3.1 Supply, Consumption and Gap of Spine Biologics 2016-2021 146

11.3.2 Global Capacity, Production, Price, Cost, Revenue, Supply and Consumption of Spine Biologics 2016-2021 147

11.3.3 North America Capacity, Production, Price, Cost, Revenue, Supply and Consumption of Spine Biologics 2016-2021 148

11.3.4 Europe Capacity, Production, Price, Cost, Revenue, Supply and Consumption of Spine Biologics 2016-2021 148

11.3.5 Asia Capacity, Production, Price, Cost, Revenue, Supply and Consumption of Spine Biologics 2016-2021 149

12 New Project Investment Feasibility Analysis of Spine Biologics 150

12.1 New Project SWOT Analysis of Spine Biologics 150

12.2 New Project Investment Feasibility Analysis of Spine Biologics 150

12.2.1 Project Name 150

12.2.2 Investment Budget 150

12.2.3 Project Product Solutions 151

13 Conclusion of the Global Spine Biologics Industry 2016 Market Research Report 152

List Of Tables and Figures

Figure Picture of Spine Biologics 1

Table Comparison of Main Models from Spine Biologics Major Manufacturers 2

Table Specification of Main Models from Spine Biologics Major Brand 2

Table Specification Comparison of Different Types of Spine Biologics 3

Figure Global Production Market Share of Spine Biologics by Type in 2015 3

Figure Bone Graft Picture 4

Figure Bone Graft Substitute Picture 4

Figure Platelet Rich Plasma Picture 5

Figure BMAC Picture 5

Table Applications of Spine Biologics 6

Figure 2015 Global Spine Biologics Major Applications Sales Share 6

Figure Anterior Cervical Discectomy and Fusion Examples 7

Figure Posterior Lumbar Interbody Fusion Examples 7

Figure Industry Chain Structure of Spine Biologics 8

Table Global Spine Biologics Major Manufacturers 9

Table Global Major Regions Spine Biologics Production Market Share in 2015 9

Table Industry Policy of Spine Biologics 10

Table Industry News List of Spine Biologics 12

Table Raw Material Suppliers Analysis 15

Table Equipment Suppliers Analysis 16

Figure 2014 APAC Overview of Average Monthly Labor Cost 17

Figure 2014 Americas Overview of Average Monthly Labor Cost 17

Figure 2014 EMEA Overview of Average Monthly Labor Cost 18

Figure 2010-2015 USA Employment Cost Index (ECI) 18

Figure 2010-2014 China Average Wage of Worker and Growth Rate (CNY/a) 19

Table 2015 Electricity Price of Industry (USD/KW·h) by Some Country 19

Table Manufacturing Cost Structure Analysis of Spine Biologics in 2015 20

Figure Manufacturing Process Analysis of Spine Biologics 21

Table Capacity (K Units) of Global Spine Biologics Key Manufacturers in 2015 22

Table Key Manufacturing Plants Distribution of Global Spine Biologics Major Manufacturers in 2015 22

Table R&D Status and Technology Source of Global Spine Biologics Key Manufacturers in 2015 23

Table Global Capacity (K Units) of Spine Biologics by Regions 2011-2016 24

Figure Global Capacity Market Share of Spine Biologics by Regions in 2011 24

Figure Global Capacity Market Share of Spine Biologics by Regions in 2015 25

Table Global Production (K Units) of Spine Biologics by Regions 2011-2016 25

Figure Global Production Market Share of Spine Biologics by Regions in 2011 25

Figure Global Production Market Share of Spine Biologics by Regions in 2015 26

Table Global Revenue (M USD) of Spine Biologics by Regions 2011-2016 26

Figure Global Revenue Market Share of Spine Biologics by Regions in 2011 26

Figure Global Revenue Market Share of Spine Biologics by Regions in 2015 27

Figure Global Capacity (K Units), Production (K Units) and Growth Rate of Spine Biologics 2011-2016 27

Figure Global Capacity Utilization Rate of Spine Biologics 2011-2016 28

Figure Global Revenue (M USD) and Growth Rate of Spine Biologics 2011-2016 28

Figure North America Capacity (K Units), Production (K Units) and Growth Rate of Spine Biologics 2011-2016 29

Figure North America Capacity Utilization Rate of Spine Biologics 2011-2016 29

Figure North America Revenue (M USD) and Growth Rate of Spine Biologics 2011-2016 30

Figure Europe Capacity (K Units), Production (K Units) and Growth Rate of Spine Biologics 2011-2016 30

Figure Europe Capacity Utilization Rate of Spine Biologics 2011-2016 31

Figure Europe Revenue (M USD) and Growth Rate of Spine Biologics 2011-2016 31

Figure Asia Capacity (K Units), Production (K Units) and Growth Rate of Spine Biologics 2011-2016 32

Figure Asia Capacity Utilization Rate of Spine Biologics 2011-2016 32

Figure Asia Revenue (M USD) and Growth Rate of Spine Biologics 2011-2016 33

Table Global Production (K Units) of Spine Biologics by Types 2011-2016 33

Figure Global Production Market Share of Spine Biologics by Types in 2011 34

Figure Global Production Market Share of Spine Biologics by Types in 2015 34

Table Global Revenue (M USD) of Spine Biologics by Types 2011-2016 35

Figure Global Revenue Market Share of Spine Biologics by Types in 2011 35

Figure Global Revenue Market Share of Spine Biologics by Types in 2015 36

Table Global and Major Manufacturers Capacity (K Units) of Spine Biologics 2011-2016 36

Table Global Capacity Market Share of Spine Biologics Major Manufacturers 2011-2016 37

Figure Global Capacity Market Share of Spine Biologics Major Manufacturers in 2011 37

Figure Global Capacity Market Share of Spine Biologics Major Manufacturers in 2015 38

Table Global and Major Manufacturers Production (K Units) of Spine Biologics 2011-2016 38

Table Global Production Market Share of Spine Biologics Major Manufacturers 2011-2016 39

Figure Global Production Market Share of Spine Biologics Major Manufacturers in 2011 39

Figure Global Production Market Share of Spine Biologics Major Manufacturers in 2015 40

Table Global and Major Manufacturers Revenue (M USD) of Spine Biologics 2011-2016 40

Table Global Revenue Market Share of Spine Biologics Major Manufacturers 2011-2016 41

Figure Global Revenue Market Share of Spine Biologics Major Manufacturers in 2011 41

Figure Global Revenue Market Share of Spine Biologics Major Manufacturers in 2015 42

Table Price (USD/Unit) of Spine Biologics by Regions 2011-2016 43

Figure Price (USD/Unit) of Spine Biologics by Regions in 2015 43

Table Cost (USD/Unit) of Spine Biologics by Regions 2011-2016 44

Figure Cost (USD/Unit) of Spine Biologics by Regions in 2015 44

Table Gross (USD/Unit) of Spine Biologics by Regions 2011-2016 44

Figure Gross (USD/Unit) of Spine Biologics by Regions in 2015 45

Table Gross Margin of Spine Biologics by Regions 2011-2016 45

Figure Gross Margin of Spine Biologics by Regions in 2015 45

Table Price (USD/Unit) of Spine Biologics by Types 2011-2016 46

Figure Price (USD/Unit) of Spine Biologics by Types in 2015 46

Table Cost (USD/Unit) of Spine Biologics by Types 2011-2016 46

Figure Cost (USD/Unit) of Spine Biologics by Types in 2015 47

Table Gross (USD/Unit) of Spine Biologics by Types 2011-2016 47

Figure Gross (USD/Unit) of Spine Biologics by Types in 2015 48

Table Gross Margin of Spine Biologics by Types 2011-2016 48

Figure Gross Margin of Spine Biologics by Types in 2015 49

Table Price (USD/Unit) of Spine Biologics by Manufacturers 2011-2016 49

Figure Price (USD/Unit) of Spine Biologics by Manufacturers in 2015 50

Table Cost (USD/Unit) of Spine Biologics by Manufacturers 2011-2016 50

Figure Cost (USD/Unit) of Spine Biologics by Manufacturers in 2015 51

Table Gross (USD/Unit) of Spine Biologics by Manufacturers 2011-2016 51

Figure Gross (USD/Unit) of Spine Biologics by Manufacturers in 2015 52

Table Gross Margin of Spine Biologics by Manufacturers 2011-2016 52

Figure Gross Margin of Spine Biologics by Manufacturers in 2015 53

Table Global Consumption Volume (K Units) of Spine Biologics by Regions 2011-2016 54

Figure Global Consumption Volume Market Share of Spine Biologics by Regions in 2011 55

Figure Global Consumption Volume Market Share of Spine Biologics by Regions in 2015 55

Table Global Consumption Value (M USD) of Spine Biologics by Regions 2011-2016 56

Figure Global Consumption Value Market Share of Spine Biologics by Regions in 2011 56

Figure Global Consumption Value Market Share of Spine Biologics by Regions in 2015 57

Figure Global Consumption Volume (K Units) and Growth Rate of Spine Biologics 2011-2016 57

Figure Global Consumption Value (M USD) and Growth Rate of Spine Biologics 2011-2016 58

Figure North America Consumption Volume (K Units) and Growth Rate of Spine Biologics 2011-2016 58

Figure North America Consumption Value (M USD) and Growth Rate of Spine Biologics 2011-2016 59

Figure Europe Consumption Volume (K Units) and Growth Rate of Spine Biologics 2011-2016 59

Figure Europe Consumption Value (M USD) and Growth Rate of Spine Biologics 2011-2016 60

Figure China Consumption Volume (K Units) and Growth Rate of Spine Biologics 2011-2016 60

Figure China Consumption Value (M USD) and Growth Rate of Spine Biologics 2011-2016 61

Figure Asia (Ex. China) Consumption Volume (K Units) and Growth Rate of Spine Biologics 2011-2016 61

Figure Asia (Ex. China) Consumption Value (M USD) and Growth Rate of Spine Biologics 2011-2016 62

Table Global Consumption Volume (K Units) of Spine Biologics by Types 2011-2016 62

Figure Global Consumption Volume Market Share of Spine Biologics by Types in 2011 63

Figure Global Consumption Volume Market Share of Spine Biologics by Types in 2015 63

Table Global Consumption Value (M USD) of Spine Biologics by Types 2011-2016 64

Figure Global Consumption Value Market Share of Spine Biologics by Types in 2011 64

Figure Global Consumption Value Market Share of Spine Biologics by Types in 2015 65

Table Global Consumption Volume (K Units) of Spine Biologics by Applications 2011-2016 65

Figure Global Consumption Volume Market Share of Spine Biologics by Applications in 2011 66

Figure Global Consumption Volume Market Share of Spine Biologics by Applications in 2015 66

Table Global Consumption Value (M USD) of Spine Biologics by Applications 2011-2016 67

Figure Global Consumption Value Market Share of Spine Biologics by Applications in 2011 67

Figure Global Consumption Value Market Share of Spine Biologics by Applications in 2015 68

Table Sale Price (USD/Unit) of Spine Biologics by Regions 2011-2016 68

Table Sale Price (USD/Unit) of Spine Biologics by Types 2011-2016 68

Table Sale Price (USD/Unit) of Spine Biologics by Applications 2011-2016 69

Table Global Supply, Consumption and Gap of Spine Biologics 2011-2016 (K Units) 70

Table North America Supply, Consumption and Gap of Spine Biologics 2011-2016 (K Units) 70

Table Europe Supply, Consumption and Gap of Spine Biologics 2011-2016 (K Units) 70

Table Asia Supply, Consumption and Gap of Spine Biologics 2011-2016 (K Units) 71

Table Global Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Spine Biologics 2011-2016 71

Table North America Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Spine Biologics 2011-2016 72

Table North America Supply, Import, Export and Consumption of Spine Biologics 2011-2016 (K Units) 72

Table Europe Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Spine Biologics 2011-2016 73

Table Europe Supply, Import, Export and Consumption of Spine Biologics 2011-2016 (K Units) 73

Table Asia Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Spine Biologics 2011-2016 74

Table Asia Supply, Import, Export and Consumption of Spine Biologics 2011-2016 (K Units) 74

Table Medtronic Company Profile 75

Figure Spine Biologics Product Picture of Medtronic 76

Table Spine Biologics Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Medtronic 2011-2016 76

Figure Spine Biologics Capacity (K Units), Production (K Units) and Growth Rate of Medtronic 2011-2016 77

Figure Spine Biologics Production (K Units) and Global Market Share of Medtronic 2011-2016 77

Table Depuy Synthes Company Profile 78

Figure Spine Biologics Product Picture of Depuy Synthes 79

Table Spine Biologics Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Depuy Synthes 2011-2016 80

Figure Spine Biologics Capacity (K Units), Production (K Units) and Growth Rate of Depuy Synthes 2011-2016 80

Figure Spine Biologics Production (K Units) and Global Market Share of Depuy Synthes 2011-2016 81

Table Stryker Corporation Company Profile 81

Figure Spine Biologics Product Picture of Stryker Corporation 82

Table Spine Biologics Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Stryker Corporation 2011-2016 83

Figure Spine Biologics Capacity (K Units), Production (K Units) and Growth Rate of Stryker Corporation 2011-2016 83

Figure Spine Biologics Production (K Units) and Global Market Share of Stryker Corporation 2011-2016 84

Table Nuvasive Company Profile 84

Figure Spine Biologics Product Picture of Nuvasive 85

Table Spine Biologics Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Nuvasive 2011-2016 86

Figure Spine Biologics Capacity (K Units), Production (K Units) and Growth Rate of Nuvasive 2011-2016 86

Figure Spine Biologics Production (K Units) and Global Market Share of Nuvasive 2011-2016 87

Table Zimmer Biomet Company Profile 87

Figure Spine Biologics Product Picture of Zimmer Biomet 88

Table Spine Biologics Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Zimmer Biomet 2011-2016 89

Figure Spine Biologics Capacity (K Units), Production (K Units) and Growth Rate of Zimmer Biomet 2011-2016 89

Figure Spine Biologics Production (K Units) and Global Market Share of Zimmer Biomet 2011-2016 90

Table Orthofix International Company Profile 90

Figure Spine Biologics Product Picture of Orthofix International 91

Table Spine Biologics Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Orthofix International 2011-2016 91

Figure Spine Biologics Capacity (K Units), Production (K Units) and Growth Rate of Orthofix International 2011-2016 92

Figure Spine Biologics Production (K Units) and Global Market Share of Orthofix International 2011-2016 92

Table Globus Medical Company Profile 93

Figure Spine Biologics Product Picture of Globus Medical 94

Table Spine Biologics Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Globus Medical 2011-2016 94

Figure Spine Biologics Capacity (K Units), Production (K Units) and Growth Rate of Globus Medical 2011-2016 95

Figure Spine Biologics Production (K Units) and Global Market Share of Globus Medical 2011-2016 95

Table Alphatec spine Company Profile 96

Figure Spine Biologics Product Picture of Alphatec spine 97

Table Spine Biologics Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Alphatec spine 2011-2016 97

Figure Spine Biologics Capacity (K Units), Production (K Units) and Growth Rate of Alphatec spine 2011-2016 98

Figure Spine Biologics Production (K Units) and Global Market Share of Alphatec spine 2011-2016 98

Table K2M Company Profile 99

Figure Spine Biologics Product Picture of K2M 100

Table Spine Biologics Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of K2M 2011-2016 100

Figure Spine Biologics Capacity (K Units), Production (K Units) and Growth Rate of K2M 2011-2016 101

Figure Spine Biologics Production (K Units) and Global Market Share of K2M 2011-2016 101

Table Exactech Company Profile 102

Figure Spine Biologics Product Picture of Exactech 103

Table Spine Biologics Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Exactech 2011-2016 103

Figure Spine Biologics Capacity (K Units), Production (K Units) and Growth Rate of Exactech 2011-2016 104

Figure Spine Biologics Production (K Units) and Global Market Share of Exactech 2011-2016 104

Table Wright Medical Technology Company Profile 105

Figure Spine Biologics Product Picture of Wright Medical Technology 106

Table Spine Biologics Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Wright Medical Technology 2011-2016 106

Figure Spine Biologics Capacity (K Units), Production (K Units) and Growth Rate of Wright Medical Technology 2011-2016 107

Figure Spine Biologics Production (K Units) and Global Market Share of Wright Medical Technology 2011-2016 107

Table X-Spine Systems Company Profile 108

Figure Spine Biologics Product Picture of X-Spine Systems 109

Table Spine Biologics Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of X-Spine Systems 2011-2016 109

Figure Spine Biologics Capacity (K Units), Production (K Units) and Growth Rate of X-Spine Systems 2011-2016 110

Figure Spine Biologics Production (K Units) and Global Market Share of X-Spine Systems 2011-2016 110

Table Nutech Company Profile 111

Figure Spine Biologics Product Picture of Nutech 112

Table Spine Biologics Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Nutech 2011-2016 112

Figure Spine Biologics Capacity (K Units), Production (K Units) and Growth Rate of Nutech 2011-2016 113

Figure Spine Biologics Production (K Units) and Global Market Share of Nutech 2011-2016 113

Table Arthrex Company Profile 114

Figure Spine Biologics Product Picture of Arthrex 115

Table Spine Biologics Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Arthrex 2011-2016 115

Figure Spine Biologics Capacity (K Units), Production (K Units) and Growth Rate of Arthrex 2011-2016 116

Figure Spine Biologics Production (K Units) and Global Market Share of Arthrex 2011-2016 116

Figure Marketing Channels of Spine Biologics 117

Table Traders or Distributors with Contact Information of Spine Biologics 118

Figure Ex-work Price, Channel Price and End Buyer Price of Spine Biologics (USD/Unit) in 2015 119

Table Regional Import, Export, and Trade of Spine Biologics (K Units) 119

Table Global Capacity (K Units) of Spine Biologics by Regions 2016-2021 121

Figure Global Capacity Market Share of Spine Biologics by Regions in 2016 121

Figure Global Capacity Market Share of Spine Biologics by Regions in 2021 122

Table Global Production (K Units) of Spine Biologics by Regions 2016-2021 122

Figure Global Production Market Share of Spine Biologics by Regions in 2016 122

Figure Global Production Market Share of Spine Biologics by Regions in 2021 123

Table Global Revenue (M USD) of Spine Biologics by Regions 2016-2021 123

Figure Global Revenue Market Share of Spine Biologics by Regions in 2016 123

Figure Global Revenue Market Share of Spine Biologics by Regions in 2021 124

Figure Global Capacity (K Units), Production (K Units) and Growth Rate of Spine Biologics 2016-2021 124

Figure Global Capacity Utilization Rate of Spine Biologics 2016-2021 124

Figure Global Revenue (M USD) and Growth Rate of Spine Biologics 2016-2021 124

Figure North America Capacity (K Units), Production (K Units) and Growth Rate of Spine Biologics 2016-2021 125

Figure North America Capacity Utilization Rate of Spine Biologics 2016-2021 125

Figure North America Revenue (M USD) and Growth Rate of Spine Biologics 2016-2021 126

Figure Europe Capacity (K Units), Production (K Units) and Growth Rate of Spine Biologics 2016-2021 126

Figure Europe Capacity Utilization Rate of Spine Biologics 2016-2021 127

Figure Europe Revenue (M USD) and Growth Rate of Spine Biologics 2016-2021 127

Figure Asia Capacity (K Units), Production (K Units) and Growth Rate of Spine Biologics 2016-2021 128

Figure Asia Capacity Utilization Rate of Spine Biologics 2016-2021 128

Figure Asia Revenue (M USD) and Growth Rate of Spine Biologics 2016-2021 129

Table Global Production (K Units) of Spine Biologics by Types 2016-2021 129

Figure Global Production Market Share of Spine Biologics by Types in 2016 130

Figure Global Production Market Share of Spine Biologics by Types in 2021 130

Table Global Revenue (M USD) of Spine Biologics by Types 2016-2021 131

Figure Global Revenue Market Share of Spine Biologics by Types in 2016 131

Figure Global Revenue Market Share of Spine Biologics by Types in 2021 132

Table Global Consumption Volume (K Units) of Spine Biologics by Regions 2016-2021 132

Figure Global Consumption Volume Market Share of Spine Biologics by Regions in 2016 133

Figure Global Consumption Volume Market Share of Spine Biologics by Regions in 2021 133

Table Global Consumption Value (M USD) of Spine Biologics by Regions 2016-2021 134

Figure Global Consumption Value Market Share of Spine Biologics by Regions in 2016 134

Figure Global Consumption Value Market Share of Spine Biologics by Regions in 2021 135

Figure Global Consumption Volume (K Units) and Growth Rate of Spine Biologics 2016-2021 135

Figure Global Consumption Value (M USD) and Growth Rate of Spine Biologics 2016-2021 136

Figure North America Consumption Volume (K Units) and Growth Rate of Spine Biologics 2016-2021 136

Figure North America Consumption Value (M USD) and Growth Rate of Spine Biologics 2016-2021 137

Figure Europe Consumption Volume (K Units) and Growth Rate of Spine Biologics 2016-2021 137

Figure Europe Consumption Value (M USD) and Growth Rate of Spine Biologics 2016-2021 138

Figure China Consumption Volume (K Units) and Growth Rate of Spine Biologics 2016-2021 138

Figure China Consumption Value (M USD) and Growth Rate of Spine Biologics 2016-2021 139

Figure Asia (Ex. China) Consumption Volume (K Units) and Growth Rate of Spine Biologics 2016-2021 139

Figure Asia (Ex. China) Consumption Value (M USD) and Growth Rate of Spine Biologics 2016-2021 140

Table Global Consumption Volume (K Units) of Spine Biologics by Types 2016-2021 140

Figure Global Consumption Volume Market Share of Spine Biologics by Types in 2016 141

Figure Global Consumption Volume Market Share of Spine Biologics by Types in 2021 141

Table Global Consumption Value (M USD) of Spine Biologics by Types 2016-2021 142

Figure Global Consumption Value Market Share of Spine Biologics by Types in 2016 142

Figure Global Consumption Value Market Share of Spine Biologics by Types in 2021 143

Table Global Consumption Volume (K Units) of Spine Biologics by Applications 2016-2021 143

Figure Global Consumption Volume Market Share of Spine Biologics by Applications in 2016 144

Figure Global Consumption Volume Market Share of Spine Biologics by Applications in 2021 144

Table Global Consumption Value (M USD) of Spine Biologics by Applications 2016-2021 145

Figure Global Consumption Value Market Share of Spine Biologics by Applications in 2016 145

Figure Global Consumption Value Market Share of Spine Biologics by Applications in 2021 146

Table Global Supply, Consumption and Gap of Spine Biologics 2016-2021 (K Units) 146

Table North America Supply, Consumption and Gap of Spine Biologics 2016-2021 (K Units) 147

Table Europe Supply, Consumption and Gap of Spine Biologics 2016-2021 (K Units) 147

Table Asia Supply, Consumption and Gap of Spine Biologics 2016-2021 (K Units) 147

Table Global Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Spine Biologics 2016-2021 147

Table North America Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Spine Biologics 2016-2021 148

Table Europe Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Spine Biologics 2016-2021 148

Table Asia Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Spine Biologics 2016-2021 149

Table New Project SWOT Analysis of Spine Biologics 150

Table Project Appraisal and Financing 151

Table New Project Investment Feasibility Analysis of Spine Biologics 151

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

2017-2021 UK Hemostasis Diagnostics Market: Emerging Opportunities and Growth Strategies for Instrument and Reagent Suppliers

Complete report $6,100.  DataPack (test volumes, sales forecasts, supplier shares) $3,950.

Summary

This comprehensive report contains 409 pages, 35 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the UK coagulation testing market duri...

  • Publish Date: February 7, 2017
  • $750
2017-2021 US Hemostasis Diagnostics Market: Emerging Opportunities and Growth Strategies for Instrument and Reagent Suppliers

Complete report $9,600.  DataPack (test volumes, sales forecasts, supplier shares) $6,200.

Summary

This comprehensive report contains 424 pages, 37 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the US coagulation testing market during the...

  • Publish Date: February 7, 2017
  • $750
2017-2021 Immunohematology and Infectious Disease Screening Market: Competitive Analysis of Major Suppliers and Emerging Market Entrants

This new report from VPGMarketResearch.com provides strategic assessments of major blood banking product suppliers and emerging market entrants. The report presents analyses of major current and emerging suppliers in terms of their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.

Con...

  • Publish Date: February 7, 2017
  • $750